Dianthus Therapeutics, Inc. · 3 months ago
Senior Director, Regulatory Combination Product
Dianthus Therapeutics, Inc. is developing innovative therapies for severe autoimmune diseases. The Senior Director, Regulatory Combination Product, will be responsible for ensuring regulatory compliance for biologics-device combination products throughout their development lifecycles, collaborating with various teams to support product development and commercialization.
BiopharmaBiotechnologyHealth Care
Responsibilities
Develop comprehensive strategies that address both biologic and device components and align with corporate goals and regulatory expectations
Provide guidance for plans and protocols for compatibility studies, design verification studies and functional stability studies, and contribute to the design of human factor studies and usability testing
Interpret regulatory regulations, standards, directives, guidelines and advise Development, Technical Operations, and Quality on their applicability to and impact on product development projects
Deliver strategic input to Design Control processes and documentation, ensuring alignment with health authority and notified body requirements and global technical standards. Review DHF documentation from a regulatory perspective
Design and execute effective submission strategies for device-related dossier components (INDs/CTAs, marketing applications, and post-approval changes) in collaboration with SMEs
Conduct precedent research to ensure creation of state-of-the-art studies
Influence cross-functional decision-making without direct authority, operating effectively in a matrixed environment
Perform assessment of change controls to identify and mitigate regulatory risks
Lead interactions with health authorities and notified bodies
Help manage device-related regulatory information in company systems
Support for other Regulatory CMC activities
Qualification
Required
A bachelor's degree in a scientific/engineering discipline
Experience as regulatory lead in pharmaceutical, biotechnology, or medical device industries, specifically with combination product filings
Strong knowledge of and broad experience with regulations, standards, directives, guidelines and requirements related to the use of combination products in global clinical studies and commercial registration
Proven track record in late‑stage development of combination products
In-depth understanding of ISO and ASTM standards relevant to combination products
Solid understanding of current industry trends and regulatory expectations associated with combination products
Good understanding of ICH guidelines and GMP requirements for development and manufacturing of biologics
Strategic acumen, collaboration, influencing skills, and communication skills are important for success
Preferred
Experience with biologics and combination products
APFS or Auto-Injector experience specifically
Company
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$639.5M2025-09-09Post Ipo Equity· $288M
2024-01-22Post Ipo Equity· $230M
2023-09-12IPO
Leadership Team
Recent News
Clinical Trials Arena
2025-12-25
Company data provided by crunchbase